KASEY STOVER: Open Payments
NPI 1568746899 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 28 payments from 17 companies in 2025. Trend: 2023 $296 · 2024 $512 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $71 |
| Lilly USA, LLC | 4 | $59 |
| Novo Nordisk Inc | 3 | $59 |
| Astellas Pharma US Inc | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Abbott Laboratories | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Viatris Specialty LLC | 1 | $24 |
| Boston Scientific Corporation | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
Products named: Veozah, MOUNJARO, Wegovy, QULIPTA, VRAYLAR, FREESTYLE LIBRE 3, Auvelity, YUPELRI.
Industry payments across PA — which companies pay providers there.
